Previous studies have indicated that the abundance of SREBP-1c is increased in NAFLD, and liver-specific SREBP-1c overexpression increased liver triglyceride content (35–39). The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.